Status:
COMPLETED
Quality of Life in Postmenopausal Women Who Are Receiving Either Exemestane or Anastrozole With or Without Celecoxib for Stage I, Stage II, or Stage IIIA Primary Breast Cancer
Lead Sponsor:
Eastern Cooperative Oncology Group
Collaborating Sponsors:
National Cancer Institute (NCI)
NCIC Clinical Trials Group
Conditions:
Breast Cancer
Eligibility:
FEMALE
Up to 120 years
Brief Summary
RATIONALE: Quality-of-life assessment in postmenopausal women who are receiving hormone therapy for breast cancer may help to determine the effects of treatment on these patients and may improve the q...
Detailed Description
OBJECTIVES: Primary * Compare treatment-related symptoms using the Functional Assessment of Cancer Therapy-Endocrine Symptoms (FACT-ES) questionnaire in postmenopausal women with receptor-positive s...
Eligibility Criteria
Inclusion
- DISEASE CHARACTERISTICS:
- Histologically confirmed invasive breast cancer
- pT1-3; pNX, pN0-2 or pN3\*; M0 NOTE: \*Only when the sole basis for this classification is the presence of 10 or more involved axillary lymph nodes
- Registered on protocol CAN-NCIC-MA27 within the past week
- Hormone receptor status:
- Estrogen receptor- and/or progesterone receptor-positive by immunohistochemistry or tumor receptor content ≥ 10 fmol/mg protein
- At least 1 tumor must be receptor-positive in patients with bilateral breast cancer
- PATIENT CHARACTERISTICS:
- Age
- Postmenopausal
- Performance status
- ECOG 0-2
- Sex
- Female
- Menopausal status
- Postmenopausal
- Life expectancy
- Not specified
- Hematopoietic
- Not specified
- Hepatic
- Not specified
- Renal
- Not specified
- Other
- Able to read, understand, and complete quality of life questionnaires
- PRIOR CONCURRENT THERAPY:
- Biologic therapy
- Not specified
- Chemotherapy
- Not specified
- Endocrine therapy
- Not specified
- Radiotherapy
- Not specified
- Surgery
- Not specified
Exclusion
Key Trial Info
Start Date :
January 26 2005
Trial Type :
OBSERVATIONAL
End Date :
January 30 2013
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00090974
Start Date
January 26 2005
End Date
January 30 2013
Last Update
June 15 2023
Active Locations (224)
Enter a location and click search to find clinical trials sorted by distance.
1
Fairbanks Cancer Treatment Center at Fairbanks Memorial Hospital
Fairbanks, Alaska, United States, 99701
2
Banner Good Samaritan Medical Center
Phoenix, Arizona, United States, 85006
3
CCOP - Western Regional, Arizona
Phoenix, Arizona, United States, 85006
4
Banner Thunderbird Medical Center
Phoenix, Arizona, United States, 85306